| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,728 | 26,988 | 30,314 | 36,269 | | Cost of Revenue | 8,117 | 9,538 | 11,275 | 12,539 | | | Gross Profit |
-
| 18,729 | 19,039 | 23,730 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,008 | 19,043 | 16,490 | 14,886 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,462 | 101,005 | 7,500 | 27,416 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (30,269) | (4,951) | (18,572) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (13,859) | (102,598) | (4,951) | (18,572) | | Interest Expense | 722 | 873 | 986 | 1,467 | | Income Before Tax | (14,581) | (103,471) | (5,937) | (20,039) | | Income Tax Expense |
-
| 7,311 | (2,700) | (8,994) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,581) | (110,782) | (3,237) | (11,045) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,581) | (110,782) | (3,237) | (11,045) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,581) | ($110,782) | ($3,237) | ($11,045) |
|
0.51% Nasdaq 0.00%
Income Statement
